Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Treatment
19 results:

  • 1. Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment.
    Qiu L; Shen R; Wei L; Xu S; Xia W; Hou Y; Cui J; Qu R; Luo J; Cao J; Yang J; Sun J; Ma R; Yu Q
    J Nanobiotechnology; 2023 Sep; 21(1):344. PubMed ID: 37741962
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis.
    Hyung J; Lee JY; Kim JE; Yoon S; Yoo C; Hong YS; Jeong JH; Kim TW; Jeon S; Jun HR; Jung CK; Jang JP; Kim J; Chun SM; Ahn JH
    ESMO Open; 2023 Jun; 8(3):101583. PubMed ID: 37327700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
    Garcia-Rendueles MER; Krishnamoorthy G; Saqcena M; Acuña-Ruiz A; Revilla G; de Stanchina E; Knauf JA; Lester R; Xu B; Ghossein RA; Fagin JA
    Mol Cancer; 2022 Dec; 21(1):213. PubMed ID: 36476495
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Application of histology-agnostic treatments in metastatic colorectal cancer.
    Sartore-Bianchi A; Agostara AG; Patelli G; Mauri G; Pizzutilo EG; Siena S
    Dig Liver Dis; 2022 Oct; 54(10):1291-1303. PubMed ID: 35701319
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of Textbook Oncologic Outcomes Following Proctectomy for Rectal cancer.
    Naffouje SA; Ali MA; Kamarajah SK; White B; Salti GI; Dahdaleh F
    J Gastrointest Surg; 2022 Jun; 26(6):1286-1297. PubMed ID: 35441331
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic alteration of Chinese patients with rectal mucosal melanoma.
    Li H; Yang L; Lai Y; Wang X; Han X; Liu S; Wang D; Li X; Hu N; Kong Y; Si L; Li Z
    BMC Cancer; 2021 May; 21(1):623. PubMed ID: 34044811
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Anal squamous cell carcinoma: a retrospective case series.
    Houlihan OA; Monaghan O; O'Sullivan S; Nugent K; Dunne M; Neary P; Cahill R; Mehigan B; McNamara DA; Salib O; Gillham C; McVey G; Faul C; Cunningham M; Armstrong J; O'Neill BDP
    Ir J Med Sci; 2022 Apr; 191(2):681-686. PubMed ID: 33977391
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Therapeutic Potential of Afatinib in nrg1 Fusion-Driven Solid Tumors: A Case Series.
    Cadranel J; Liu SV; Duruisseaux M; Branden E; Goto Y; Weinberg BA; Heining C; Schlenk RF; Cheema P; Jones MR; Drilon A; Trombetta D; Muscarella LA; Tolba K; Gounant V; Cseh A; Solca F; Laskin JJ; Renouf DJ
    Oncologist; 2021 Jan; 26(1):7-16. PubMed ID: 32852072
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Unmet Needs of the Diagnosis, Staging, and treatment of Gastrointestinal Tumors.
    Halama N; Haberkorn U
    Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Short and long course neoadjuvant therapy compared for management of locally advanced rectal cancer: 11 years' experience at a regional centre.
    Ngoo AG; Tan AHM; Mushaya CD; Ho YH
    ANZ J Surg; 2020 May; 90(5):812-820. PubMed ID: 31957264
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prevalence and influence on outcome of HER2/neu, HER3 and nrg1 expression in patients with metastatic colorectal cancer.
    Stahler A; Heinemann V; Neumann J; Crispin A; Schalhorn A; Stintzing S; Giessen-Jung C; Fischer von Weikersthal L; Vehling-Kaiser U; Stauch M; Quietzsch D; Holch JW; Kruger S; Haas M; Michl M; von Einem J; Kirchner T; Jung A; Modest DP
    Anticancer Drugs; 2017 Aug; 28(7):717-722. PubMed ID: 28582279
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dietary peptides from the non-digestible fraction of Phaseolus vulgaris L. decrease angiotensin II-dependent proliferation in HCT116 human colorectal cancer cells through the blockade of the renin-angiotensin system.
    Luna-Vital DA; Liang K; González de Mejía E; Loarca-Piña G
    Food Funct; 2016 May; 7(5):2409-19. PubMed ID: 27156533
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer.
    Nagaoka T; Kitaura K; Miyata Y; Kumagai K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
    Mol Med Rep; 2016 Apr; 13(4):3514-20. PubMed ID: 26935861
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated colorectal cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The role of surgical methods in the treatment of anorectal malignant melanoma (AMM).
    Keskin S; Tas F; Karabulut S; Yildiz I; Kiliç L; Ciftci R; Vatansever S
    Acta Chir Belg; 2013; 113(6):429-33. PubMed ID: 24494470
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Levothyroxine and lung cancer in females: the importance of oxidative stress.
    Cornelli U; Belcaro G; Recchia M; Finco A
    Reprod Biol Endocrinol; 2013 Aug; 11():75. PubMed ID: 23924086
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models.
    Oliveras-Ferraros C; Vazquez-Martin A; Queralt B; Adrados M; Ortiz R; Cufí S; Hernández-Yagüe X; Guardeño R; Báez L; Martin-Castillo B; Pérez-Martínez MC; Lopez-Bonet E; De Llorens R; Bernadó L; Brunet J; Menendez JA
    Int J Oncol; 2011 Dec; 39(6):1455-79. PubMed ID: 21833472
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Regulation of cyclooxygenase-2 pathway by HER2 receptor.
    Vadlamudi R; Mandal M; Adam L; Steinbach G; Mendelsohn J; Kumar R
    Oncogene; 1999 Jan; 18(2):305-14. PubMed ID: 9927187
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
    Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
    J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.